About Synexus Clinical Research US, Inc
Clinical Trials at Synexus Clinical Research US, Inc
During the past decade, Synexus Clinical Research US, Inc conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Synexus Clinical Research US, Inc" #1 sponsor was "Allergan" with 1 trials, followed by "Bavarian Nordic" with 1 trials
sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored and "LG Chem"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Clinical Research US, Inc"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Synexus Clinical Research US, Inc
According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc" are
"Diabetes Mellitus" (1 trials), "Dyslipidemia" (1 trials), "Gastroparesis" (1 trials), "Gout" (1 trials) and "Hyperuricemia" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc" in a lesser frequency.
Clinical Trials Intervention Types at Synexus Clinical Research US, Inc
Most popular intervention types in "Synexus Clinical Research US, Inc" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials), "K-877" (1 trials), "LC350189 formulated capsule" (1 trials) and "MVA-BN-RSV vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Clinical Research US, Inc
The vast majority of trials in "Synexus Clinical Research US, Inc" are
5 trials for "All" genders.
Clinical Trials Status at Synexus Clinical Research US, Inc
Currently, there are NaN active trials in "Synexus Clinical Research US, Inc".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Synexus Clinical Research US, Inc,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research US, Inc, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".